Escalate
Payments companies reported to CMS as associated with Escalate. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Escalate, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Escalate
These are the largest totals companies reported as associated with Escalate. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| John Ratliff | Stanford, CA | Neurological Surgery | $750.00 |
| Kern Singh | Chicago, IL | Orthopaedic Surgery of The Spine | $655.20 |
| Sebastian Rivera | Orlando, FL | Orthopaedic Surgery of The Spine | $508.56 |
| Jason Savage | Cleveland, OH | Orthopaedic Surgery of The Spine | $377.72 |
| Maksim Shlykov | Baltimore, MD | Orthopaedic Surgery of The Spine | $244.25 |
| James Boddu | Chicago, IL | Neurological Surgery | $236.66 |
| Joseph Gjolaj | Miami, FL | Orthopaedic Surgery | $234.79 |
| Michael Wang | Miami, FL | Neurological Surgery | $232.95 |
| Joacir Graciolli Cordeiro | Miami, FL | Neurological Surgery | $215.99 |
| Matthew Philippi | Salt Lake City, UT | Orthopaedic Surgery | $197.59 |
Prescribed Escalate?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.